Abstract
Abstract
Purpose of Review
Hepatitis B (HBV) remains a health threat around the world. Hepatitis C is closer to meeting the World Health Organization’s 2030 elimination goal compared to HBV. To achieve a successful micro-elimination and macro-elimination, there are certain objectives that need to be met.
Recent Findings
HBV infects more than 262 million people worldwide and is associated with significant morbidity and increased mortality. There have been previous HBV and hepatitis C virus micro-elimination trials with varying success. Micro-elimination programs should be designed to move services forward with a plethora of avenues for monitoring, testing, and treatment.
Summary
Ultimately, successful and maintained micro-elimination is needed to achieve macro-elimination of HBV. Here, we propose 5 core tenets of micro-elimination that can be expanded to macro-elimination; these 5-line guidelines provide for 5 pillars of HBV management that support a path to a successful global elimination of HBV.
Publisher
Springer Science and Business Media LLC
Reference103 articles.
1. Tripathi N. Mousa OY. Hepatitis B. StatPearls. 2022. https://www.statpearls.com/point-of-care/22788. Accessed 30 April 2023
2. Wong RJ, Brosgart CL, Welch S, Block T, Chen M, Cohen C, et al. An updated assessment of chronic hepatitis B prevalence among foreign-born persons living in the United States. Hepatology. 2021;74(2):607–26.
3. World Health Organization. Combating hepatitis B and C to reach elimination by 2030: advocacy brief. https://apps.who.int/iris/handle/10665/206453
4. Polaris Observatory. HCV at-a-glance. Regions - Database. CDA Foundation website. https://cdafound.org/polaris-regions-database/. Accessed 10 November 2023
5. Popping S, Bade D, Boucher C, van der Valk M, El-Sayed M, Sigurour O, et al. The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals. J Virus Erad. 2019;5(1):60–6.